Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | -2.85% | $ 860.05M | $ 24.49M |
3/31/2025 | -4.77% | $ 513.64M | $ 24.49M |
12/31/2024 | -5.36% | $ 457.26M | $ 24.49M |
9/30/2024 | -4.74% | $ 516.52M | $ 24.49M |
6/30/2024 | 0% | $ 630.03M | $ 0 |
3/31/2024 | 0% | $ 472.22M | $ 0 |
12/31/2023 | 0% | $ 488.97M | $ 0 |
9/30/2023 | -6.93% | $ 360.52M | $ 24.99M |
6/30/2023 | -3.89% | $ 642.3M | $ 24.99M |
3/31/2023 | -8.57% | $ 291.29M | $ 24.95M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for UROGEN PHARMA LTD is calculated as follows: (-1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 549.9M ]
(=) Debt Paydown Yield [ 0% ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -11.5% |
max | 11.52% |
average | -0.08% |
median | 0% |
std | 3.82% |